Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 4/20 | 0.73 |
| ▸ | ESR1 | P03372 | 2/20 | 0.63 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.63 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.63 |
| ▸ | TACR2 | P21452 | 2/20 | 0.63 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.63 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.63 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.63 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | SHBG | P04278 | 1/20 | 0.63 |
| ▸ | TP53 | P04637 | 1/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.63 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.63 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.63 |
| ▸ | HTR2C | P28335 | 1/20 | 0.63 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.63 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.63 |
| ▸ | TST | Q16762 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27946204 | 1.00 | KCNH2 (0.73) | KCNH2ESR1ADRA2AADORA3TACR2 | |
| SCHEMBL5271597 | 1.00 | KCNH2 (0.73) | KCNH2ESR1ADRA2AADORA3TACR2 | |
| SCHEMBL28265190 | 1.00 | KCNH2 (0.73) | KCNH2ESR1ADRA2AADORA3TACR2 | |
| SCHEMBL3261675 | 1.00 | KCNH2 (0.73) | KCNH2ESR1ADRA2AADORA3TACR2 | |
| SCHEMBL5599404 | 1.00 | KCNH2 (0.73) | KCNH2ESR1ADRA2AADORA3TACR2 | |
| SCHEMBL811576 | 1.00 | KCNH2 (0.73) | KCNH2ESR1ADRA2AADORA3TACR2 | |
| SCHEMBL5834756 | 1.00 | KCNH2 (0.73) | KCNH2ESR1ADRA2AADORA3TACR2 | |
| SCHEMBL28816241 | 1.00 | KCNH2 (0.73) | KCNH2ESR1ADRA2AADORA3TACR2 | |
| SCHEMBL11959874 | 1.00 | KCNH2 (0.73) | KCNH2ESR1ADRA2AADORA3TACR2 | |
| SCHEMBL2056149 | 0.98 | KCNH2 (0.70) | KCNH2ESR1ADRA2AADORA3TACR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1244736-B1 | POLYCARBONATE-CONTAINING LIQUID CHEMICAL FORMULATION AND METHODS FOR MAKING AND USING POLYCARBONATE FILM | CANDESCENT INTELLECTUAL PROP (US) | 2006-12-20 | — | — | EP | claimed |
| US-6500885-B1 | UNIFORM THIN FILMS; SMALL PARALLEL APERTURES THROUGH THE FILM, PARTICULARLY FOR USE IN DEFINING OPENINGS IN THE GATE LAYER OF A GATED ELECTRON EMITTER; SOLUTION WITH SOLVENT | CANDESCENT TECHNOLOGIES CORPORATION | 2002-12-31 | — | — | US | claimed |
| EP-4347102-A1 | METHOD FOR PRODUCING PHOSGENE | BASF SE (DE) | 2024-04-10 | — | — | EP | disclosed |
| CN-103421480-B | Surfactant oil displacement composition and method of making the same | SINOPEC CORP. (CN) | 2015-08-12 | — | — | CN | disclosed |
| EP-2563818-B1 | CASSIA DERIVATIVES | LUBRIZOL ADVANCED MAT INC (US) | 2014-12-17 | — | — | EP | disclosed |
| CN-103421480-A | Oil displacement surfactant composition and preparation method thereof | CHINA PETROLEUM & CHEMICAL | 2013-12-04 | — | — | CN | disclosed |
| US-20130129639-A1 | Cassia Derivatives | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2013-05-23 | — | — | US | disclosed |
| EP-2563818-A1 | CASSIA DERIVATIVES | Lubrizol Advanced Materials, Inc. (US) | 2013-03-06 | — | — | EP | disclosed |
| CN-102933607-A | Cassia derivatives | LUBRIZOL ADVANCED MAT INC | 2013-02-13 | — | — | CN | disclosed |
| EP-2240474-B1 | CYCLIC PYRIDYL-N-(1,3,4)-THIADIAZOL-2-YL-BENZENE SULFONAMIDES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS | SANOFI SA (FR) | 2012-03-14 | — | — | EP | disclosed |
| WO-2011137218-A1 | CASSIA DERIVATIVES | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2011-11-03 | — | — | WO | disclosed |
| CN-101454922-A | Charge injection layer for electro-optical devices | UNI DE VALENCIA ESTUDI GENERA (ES) | 2009-06-10 | — | — | CN | disclosed |
| US-5397447-A | Low ionic strength, low energy reactions | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1995-03-14 | — | — | US | disclosed |
| US-5296106-A | Dispersing reaction enhancer in fluidic medium, electrifying preactivation mixture to ionic equilibrium, dispersing reactant, electrifying, collecting product | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1994-03-22 | — | — | US | disclosed |
| US-5282936-A | Using a stable, nonsoluble, porous inorganic nonconductive solid, e.g., a zeolite; low temperature and energy | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1994-02-01 | — | — | US | disclosed |
| WO-1993014243-A1 | DECOMPOSITION OF HALOGENATED AND POLYHALOGENATED ORGANIC MATERIALS BY ELECTRIFIED MICROHETEROGENEOUS CATALYSIS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1993-07-22 | — | — | WO | disclosed |
| WO-1993014242-A1 | ELECTRIFIED MICROHETEROGENEOUS CATALYSIS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1993-07-22 | — | — | WO | disclosed |
| EP-0021806-A1 | 2,3-Dihydro-imidazo (2,1-b) benzothiazole derivatives and pharmaceutical compositions containing them | JANSSEN PHARMACEUTICA N.V. (BE) | 1981-01-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130129639-A1 | Cassia Derivatives | MAN1B1, SIGLEC7, MAN2B2 | KCNH2 3513/4885ESR1 4202/4885ADRA2A 3658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.